If you are considering TMS therapy in Kalamazoo, the most useful first step is a careful psychiatric evaluation, followed by clear answers about candidacy, safety, scheduling, and how progress will be measured. TMS is a noninvasive, prescription treatment that uses magnetic pulses to stimulate targeted areas of the brain. The U.S. Food and Drug Administration classifies repetitive TMS systems for major depressive disorder as Class II medical devices with special controls.[1]
That description explains the technology, but it does not tell you whether a particular clinic or treatment plan is right for you. These seven questions will help you move from general research to an informed conversation with a TMS provider.
Quick guide
- Am I a reasonable candidate for TMS?
- Which FDA-cleared device and protocol would you use?
- Who evaluates me and supervises treatment?
- What does the schedule require in real life?
- What side effects and safety issues should I understand?
- How will we measure whether treatment is helping?
- What will insurance need before treatment can begin?
1. Am I a reasonable candidate for TMS?
TMS is often discussed when major depression has not improved enough with antidepressant treatment. The FDA-cleared indication for the NeuroStar system includes adults with major depressive disorder who did not achieve satisfactory improvement from prior antidepressant medication in the current episode.[2] The exact indication can vary by device and age group, so an evaluation should be specific rather than assumed.
A good candidacy assessment goes beyond counting medications. Expect questions about:
- your current symptoms and how they affect daily life;
- previous diagnoses, medications, psychotherapy, benefits, and side effects;
- periods of unusually high energy, reduced need for sleep, agitation, or impulsivity;
- neurological history, including seizures, head injury, stroke, or severe headaches;
- implanted metal or electronic devices;
- current medications and substances that may affect seizure risk; and
- current suicidal thoughts or recent changes in safety.
Bring a medication list or pharmacy history if you can. Depression can make dates and doses difficult to recall, and incomplete memory should never become a source of shame. Records help the clinician determine whether previous treatments were adequate and whether something important deserves another look.
An evaluation can also uncover reasons to change direction. TMS may not be appropriate for every person, and a responsible clinician should be willing to say so.
2. Which FDA-cleared device and protocol would you use?
“TMS” describes a family of treatments, not one identical procedure. Devices can differ in their cleared indications, coils, pulse patterns, treatment times, and protocols. Ask for the name of the system the clinic uses and why the proposed protocol fits your diagnosis and treatment history.
Kalamazoo TMS & Behavioral Health uses the NeuroStar Advanced Therapy System. FDA records identify NeuroStar as a transcranial magnetic stimulator and document its clearance through the 510(k) process.[2] “FDA-cleared” is the accurate regulatory term for this type of device.
You can also ask:
- What condition are you treating?
- Is the proposed use within the device’s cleared indication?
- How is the treatment location determined?
- Will the protocol stay the same throughout the course?
- What would lead the clinician to adjust or pause treatment?
The first treatment generally includes motor-threshold mapping. This helps the team determine an individualized stimulation level. A clear explanation should make the process easier to understand without suggesting that every person receives the same settings.
For a closer look at the equipment used by the practice, visit the NeuroStar TMS page.
3. Who evaluates me and supervises treatment?
TMS is delivered in an outpatient setting, but it is still medical care. FDA documentation for cleared TMS systems describes prescription use under the supervision of a licensed physician.[3]
Ask who will:
- complete the psychiatric evaluation;
- confirm the diagnosis and indication;
- review medications and safety factors;
- establish the treatment settings;
- monitor symptom change and adverse effects; and
- respond if symptoms worsen or an urgent concern arises.
You will likely spend much of the treatment course with a TMS technician. That person should be trained on the clinic’s system and able to reach the supervising clinician when a concern falls outside routine treatment.
Consistency matters here. You should know how information moves from the technician to the clinician and when formal follow-up visits occur. A clinic should also explain whom to call after hours and what situations require emergency help.
Kalamazoo TMS & Behavioral Health is led by Dr. Ruqiya Shama Tareen, a double board-certified psychiatrist. You can meet the clinical team before requesting an evaluation.
4. What does the schedule require in real life?
TMS does not require anesthesia, and patients remain awake during treatment. The schedule, however, is more intensive than an occasional office visit.
At Kalamazoo TMS, a typical NeuroStar course may involve 36 sessions over approximately six weeks, usually five visits per week. Depending on the prescribed protocol, a session may last about 19 to 37 minutes. Your own schedule may differ, and your clinician should confirm it before treatment begins.
Look at the full time commitment, including:
- travel to and from the Portage office;
- parking, check-in, and possible delays;
- work or school arrangements;
- childcare or caregiving responsibilities; and
- transportation during winter weather or difficult symptom days.
The clinic is at 5930 Lovers Lane, third floor, Portage, Michigan 49002. That location may be convenient for people traveling from Kalamazoo, Portage, Oshtemo, Texas Corners, Mattawan, Paw Paw, Comstock, Vicksburg, Battle Creek, and other Southwest Michigan communities.
Ask what happens if you miss a session. Avoid guessing that one absence will ruin treatment, but do tell the team about predictable barriers early. A schedule only works if it can coexist with your life.
For a session-by-session overview, read what TMS therapy feels like.
5. What side effects and safety issues should I understand?
TMS is noninvasive, but “noninvasive” does not mean “no side effects.” Common concerns can include scalp discomfort or headache during or after treatment. Some people find the tapping sensation unfamiliar or uncomfortable, especially early in the course.
Seizure is a serious but uncommon risk. FDA guidance calls for careful screening of factors that may alter seizure threshold, including certain neurological conditions and medications.[1] It also identifies implanted metal or devices in or near the head as important safety concerns. Hearing protection is used during treatment because the system produces repeated clicking sounds.
Tell the clinician about:
- any implanted medical or electronic device;
- metal in or near the head, apart from routine dental work;
- a personal or family history of seizures;
- stroke, traumatic brain injury, brain surgery, or neurological illness;
- pregnancy or the possibility of pregnancy;
- medication changes, heavy alcohol use, or withdrawal; and
- worsening depression, unusual behavior, or suicidal thoughts.
Do not rely on a general checklist to clear yourself for treatment. The clinic needs to review the device, location of any implant or metal, medical history, and current medications.
If you have thoughts of suicide, feel unable to stay safe, or may act on a plan, call or text 988 for the Suicide & Crisis Lifeline. Call 911 or go to the nearest emergency department if there is immediate danger.
6. How will we measure whether treatment is helping?
“Feeling better” matters, but depression can make gradual improvement hard to recognize. A strong treatment plan combines your own experience with consistent measures.
Ask which rating scale the clinic uses and how often it will be repeated. The Patient Health Questionnaire-9, or PHQ-9, is one common tool. A score is not a diagnosis and should not replace conversation, but tracking the same measure over time can show whether symptoms are moving.
Also choose two or three functional signs that matter to you. Examples include:
- getting out of bed at a consistent time;
- returning calls or messages;
- preparing a meal;
- concentrating long enough to read;
- attending work more regularly;
- resuming a hobby; or
- feeling present with family.
Research results should be discussed with context. A meta-analysis of 23 randomized controlled trials in treatment-resistant depression found response rates of about 25% with active unilateral or bilateral rTMS, compared with approximately 7% to 11% with sham treatment. Remission rates were about 16% to 17% with active treatment, compared with 2% to 6% with sham.[4] Those pooled trial results do not predict an individual outcome. Protocols, patient populations, definitions, and real-world clinical results vary.
Kalamazoo TMS reports more than 7,000 TMS sessions delivered by the practice. Clinic experience is useful, but it should accompany an honest discussion of uncertainty. Ask what the team will do if improvement is partial, slow, or absent.
7. What will insurance need before treatment can begin?
Insurance authorization is often the least visible part of the process until it creates a delay. Requirements vary by plan and may include documentation of diagnosis, antidepressant trials, medication doses and durations, psychotherapy, or standardized symptom scores.
Before your evaluation, gather what you have:
- your insurance card;
- a current medication list;
- names and approximate dates of past antidepressants;
- reasons each medication was stopped;
- prior psychiatric records, if available; and
- the name of your current therapist or prescriber.
Kalamazoo TMS states that its team submits prior-authorization paperwork after the initial evaluation when TMS is clinically appropriate. The clinic also explains that coverage and out-of-pocket responsibility depend on the plan, deductible, coinsurance, and copays.
Call the number on your insurance card to verify mental-health benefits and confirm whether the clinic is in network. Then compare the insurer’s information with the clinic’s estimate. This extra call can reduce surprises.
The practice accepts several major insurance plans but does not accept Medicaid. See the current insurance and payment information or call the office for plan-specific questions.
What should you bring to a TMS consultation in Kalamazoo?
You do not need a perfectly organized medical history. A one-page note is enough to start:
- the symptoms that interfere most with your day;
- treatments you have tried and what happened;
- current medications and supplements;
- medical conditions, surgeries, implants, or metal;
- questions about safety, time, insurance, and outcomes; and
- one description of what meaningful improvement would look like.
Consider bringing a trusted support person if that helps you remember information. Ask for written next steps before leaving. Depression can affect concentration, and a good consultation should account for that.
Frequently asked questions about TMS therapy in Kalamazoo
Is TMS the same as ECT?
No. TMS uses magnetic pulses delivered through a coil placed against the scalp. It does not require anesthesia, and it is performed while the patient is awake. ECT is a different medical procedure with different preparation, monitoring, benefits, and risks.
Can I drive after a TMS session?
TMS does not involve sedation or anesthesia, and many patients return to normal activities after a routine session. Your clinician should give individualized instructions, especially if symptoms, another condition, or another treatment affects driving safety.
How many TMS sessions will I need?
A typical NeuroStar course at Kalamazoo TMS may include 36 sessions over about six weeks, often five visits per week. The prescribed course can vary according to the indication, protocol, response, and clinician’s judgment.
Does insurance cover TMS therapy?
Many plans cover TMS when their clinical and documentation criteria are met, but requirements and patient costs differ. Verification and prior authorization are not a guarantee of full payment. Ask both the insurer and clinic for plan-specific information.
Where is Kalamazoo TMS located?
The clinic is at 5930 Lovers Lane, third floor, Portage, MI 49002, serving patients from Kalamazoo and surrounding Southwest Michigan communities.
A good consultation should leave you clearer
Choosing TMS therapy in Kalamazoo should begin with more than a treatment pitch. You deserve a careful evaluation, plain answers about the device and protocol, realistic expectations, and a plan for measuring change.
Kalamazoo TMS & Behavioral Health offers TMS evaluations at its Portage office for people across Southwest Michigan. Request a TMS consultation or call 269-381-6950 to discuss your treatment history and next steps.
This article is educational and does not replace individualized medical advice, diagnosis, or emergency care.
References
- U.S. Food and Drug Administration. “Repetitive Transcranial Magnetic Stimulation (rTMS) Systems: Class II Special Controls Guidance.”
- U.S. Food and Drug Administration. “510(k) Premarket Notification: NeuroStar, K222230.”
- U.S. Food and Drug Administration. “510(k) Substantial Equivalence Letter: NeuroStar Advanced Therapy System, K230029.”
- Sehatzadeh S, et al. “Unilateral and bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression: a meta-analysis of randomized controlled trials over 2 decades.” Journal of Psychiatry & Neuroscience. 2019;44(3):151-163.
